Yabao Pharmaceutical Group Co., Ltd

SHSE:600351 Voorraadrapport

Marktkapitalisatie: CN¥4.4b

Yabao Pharmaceutical Group Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Wei Ren

Algemeen directeur

CN¥2.1m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Yabao Pharmaceutical Group (SHSE:600351) Seems To Use Debt Rather Sparingly

Oct 01
Yabao Pharmaceutical Group (SHSE:600351) Seems To Use Debt Rather Sparingly

Yabao Pharmaceutical Group's (SHSE:600351) Strong Earnings Are Of Good Quality

May 02
Yabao Pharmaceutical Group's (SHSE:600351) Strong Earnings Are Of Good Quality

CEO

Wei Ren (38 yo)

no data

Tenure

CN¥2,073,700

Compensatie

Mr. Wei Ren serves as General Manager and Vice Chairman at Yabao Pharmaceutical Group Co., Ltd and served as its Deputy General Manager. Mr. Wei served as General manager in Beijing Yabao Investment Manage...